Series C funding round for Alto Neuroscience raising $45M in November 2023
Series C funding round for Alto Neuroscience raising $45M in November 2023
| Investor | Firm Type | Partner |
|---|
InVivium CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Eli Lilly |
| Angel | Scott Hartley |
| Angel | Tim Kendall |
This company has completed 8 funding rounds. Current round is highlighted.
Total Raised
$277M
Top Valuation
-
Alto Neuroscience raised $45M in a Series C round.
The round was announced on 11/01/23.
The round was led by Michael Liang.